FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a generic version of solifenacin succinate for overactive bladder under ANDA 202551. Actavis Pharma, Inc. is the applicant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin succinate (solifenacin)

Snippet

ORIG AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)